Metraipolis › archive › dc_7fcda93d3510

Artificial intelligence advancements in monoclonal antibody development technology — Europe PMC PMID:42427491

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42427491
DOI: 10.3389/fimmu.2026.1802038
License (as archived): solo-consultazione
Archived: 2026-10-19T02:28:27.624Z
SHA-256 of the archived text: 4fe089d2acbe48b2265f6831ea958b3f7d0c7f34faa23cc0969a892db24bbe25
Stable URL of this page: https://metraipolis.com/documento/dc_7fcda93d3510

How to cite

Artificial intelligence advancements in monoclonal antibody development technology — Europe PMC PMID:42427491 — Europe PMC (en), https://europepmc.org/article/MED/42427491 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fcda93d3510 (Metraipolis archive dc_7fcda93d3510, sha256 4fe089d2acbe48b2265f6831ea958b3f7d0c7f34faa23cc0969a892db24bbe25)

BibTeX

@misc{dc7fcda93d3510,
  title = {Artificial intelligence advancements in monoclonal antibody development technology — Europe PMC PMID:42427491},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42427491},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fcda93d3510; sha256 4fe089d2acbe48b2265f6831ea958b3f7d0c7f34faa23cc0969a892db24bbe25},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42427491. Agents can read the archived copy with the MCP tool read_document.